BB-18-OM53_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 1-{(S)-3-[3-(4-Chloro-phenoxy)-azetidin-1-yl]-1-hydroxymethyl-propyl}-3-(5-cyclopropyl-2-methyl-2H-pyrazol-3-yl)-urea, Chemokine CCR3 Antagonists targeting CCR3 (Novartis, 10127259)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10127259
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the BB-18-OM53_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
LSM7 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) 0.404255
ZMPSTE24 zinc metallopeptidase STE24 0.386478
MDK midkine (neurite growth-promoting factor 2) 0.386478
IGFBP1 insulin-like growth factor binding protein 1 0.272074
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 0.263919
RPL41 ribosomal protein L41 0.24548

decreased expression

Symbol Name Standardized Value
RPL11 ribosomal protein L11 -0.977687
RXYLT1 ribitol xylosyltransferase 1 -0.429775
RBPJ recombination signal binding protein for immunoglobulin kappa J region -0.348185
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha -0.293986
MCFD2 multiple coagulation factor deficiency 2 -0.293986
ZNF618 zinc finger protein 618 -0.268146
RAD21 RAD21 homolog (S. pombe) -0.261309